Skip to main content

Table 2 Dimensions of knowledge translation (knowledge gain; behavior modification)

From: Knowledge translation on dementia: a cluster randomized trial to compare a blended learning approach with a "classical" advanced training in GP quality circles

Quantitative parameters Qualitative parameters (following a structured interview guideline)
number of participants, response of questionnaires, use of training measures • questions regarding user behavior
• identification of barriers
knowledge gain measured by two questionnaires (pre- and post test) • subjective evaluation of knowledge gain
"behavior modification screening" gathered by EBM2000plus (GOÄ):  
• (03313 orientation survey of psychopathological status)
• 03314 (857) mental tests
• 03341 GP-geriatric basic assessment
investigation at t2: assessment of 4 quarters before and 2 quarters after intervention
• self-evaluation of behavior
• identification of barriers
„behavior modification diagnosis/differential diagnosis" assessed via six figures of ICD-10-GM 2005: F00, F01, F02, F03, F07, G32, R54
data gathered at t2: assessment of 4 quarters before and 2 quarters after intervention
• question whether diagnostic behavior has changed
• identification of barriers
„behavior modification therapy" ascertained via prescriptions of anti-dementives*:  
• cholinesterase inhibitors
• memantine
• ginkgo biloba compounds
• piracetam
investigation at t2: assessment of 4 quarters before and 2 quarters after intervention
• identify whether there is an increase in the prescription of evaluated anti-dementives (e.g. cholinesterase inhibitors, memantines) and whether there is a decrease in the prescription of untested or unreliable anti-dementives (e.g. ginkgo biloba compounds, piracetam)
• question regarding future drug therapy
• identification of barriers
„behavior modification treatment" gathered by EBM2000plus:
03001 coordination of GP-related care
03002 coordination of GP-related care in nursing homes
21230 continuous co-care in the domestic environment
21231 continuous co-care in a nursing facility
21232 psychiatric treatment
investigation at t2: assessment of 4 quarters before and 2 quarters after intervention
• question regarding prescription of non drug-related therapy
• question regarding support groups for family members
• interaction with patients and family members when patient is suspected to suffer from dementia and when the diagnosis has been confirmed
• identification of barriers
  1. * Based on the most frequent prescriptions in Germany 2003 [77]